Research Paper Volume 15, Issue 15 pp 7451—7475
SLC1A5 is a novel biomarker associated with ferroptosis and the tumor microenvironment: a pancancer analysis
Figure 1. Basic information on SLC1A5 across cancers. (A) Expression levels of SLC1A5 in normal and cancerous tissues. (B) Immunohistochemistry and HE staining of SLC1A5 in normal brain and glioma tissues. (C) Alteration frequency of SLC1A5 across cancers based on the cBioPortal database. (D) Immunofluorescence images of SLC1A5 protein expression in the nucleus, endoplasmic reticulum (ER), and microtubules in A-431 and U-251 cells. (E) The protein‒protein interaction (PPI) network shows the proteins interacting with SLC1A5.